AMP Capital Investors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-272,225
Closed -$26.9M 1285
2019
Q3
$26.9M Sell
272,225
-12,640
-4% -$1.2M 0.15% 172
2019
Q2
$26.3M Sell
284,865
-26,394
-8% -$2.51M 0.15% 174
2019
Q1
$27.2M Sell
311,259
-159,077
-34% -$13.9M 0.15% 165
2018
Q4
$29.4M Buy
470,336
+93,589
+25% +$6.91M 0.19% 140
2018
Q3
$33.6M Sell
376,747
-34,807
-8% -$3.08M 0.18% 142
2018
Q2
$32.7M Sell
411,554
-62,944
-13% -$5.23M 0.18% 147
2018
Q1
$42M Buy
474,498
+81,354
+21% +$7.81M 0.24% 111
2017
Q4
$41M Sell
393,144
-58,133
-13% -$6.56M 0.22% 113
2017
Q3
$65.8M Buy
451,277
+10,230
+2% +$1.39M 0.37% 70
2017
Q2
$58.1M Buy
441,047
+37,658
+9% +$4.61M 0.34% 77
2017
Q1
$50.2M Buy
403,389
+35,254
+10% +$4.22M 0.3% 81
2016
Q4
$43M Sell
368,135
-104,718
-22% -$11.7M 0.26% 89
2016
Q3
$48.6M Buy
472,853
+49,575
+12% +$5.37M 0.3% 82
2016
Q2
$41.8M Buy
423,278
+3,657
+0.9% +$378K 0.28% 79
2016
Q1
$41.5M Sell
419,621
-32,334
-7% -$3.33M 0.28% 85
2015
Q4
$54.5M Sell
451,955
-87,370
-16% -$10.1M 0.37% 65
2015
Q3
$56.8M Sell
539,325
-15,964
-3% -$1.98M 0.41% 61
2015
Q2
$63.8M Buy
555,289
+96,648
+21% +$11M 0.41% 60
2015
Q1
$55M Sell
458,641
-3,681
-0.8% -$440K 0.33% 79
2014
Q4
$52.5M Sell
462,322
-54,074
-10% -$5.7M 0.32% 78
2014
Q3
$49.4M Buy
+516,396
New +$46.6M 0.31% 80
2014
Q2
Sell
-694,686
Closed -$48.4M 1318
2014
Q1
$48.4M Buy
694,686
+86,218
+14% +$6.83M 0.33% 75
2013
Q4
$51.4M Buy
608,468
+4,776
+0.8% +$378K 0.36% 65
2013
Q3
$46.7M Buy
603,692
+130,696
+28% +$9.16M 0.36% 59
2013
Q2
$28M Buy
+472,996
New +$28.5M 0.22% 106

Other funds holding CELG

AMP Capital Investors's CELG Position: Q4 2019 in Review

AMP Capital Investors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 272,225 shares — an estimated $26.9M sold.

AMP Capital Investors first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $65.8M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • AMP Capital Investors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • AMP Capital Investors sold 272,225 Celgene Corp shares in Q4 2019, an estimated $26.9M.
  • AMP Capital Investors first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • AMP Capital Investors's Celgene Corp position peaked at $65.8M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on AMP Capital Investors's 13F filing for Q4 2019, filed 13 Feb 2020.